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Aβ(1−42) peptide, found as aggregated species in Alzheimer's disease brain, is linked to the onset of Alzheimer's disease. Many reports have
linked metals to inducing Aβ aggregation and amyloid plaque formation. Aβ(25–35), a fragment from the C-terminal end of Aβ(1−42), lacks the
metal coordinating sites found in the full-length peptide and is neurotoxic to cortical cortex cell cultures. We report solid-state NMR studies of
Aβ(25–35) in model lipid membrane systems of anionic phospholipids and cholesterol, and compare structural changes to those of Aβ(1–42).
When added after vesicle formation, Aβ(25–35) was found to interact with the lipid headgroups and slightly perturb the lipid acyl-chain region;
when Aβ(25–35) was included during vesicle formation, it inserted deeper into the bilayer. While Aβ(25–35) retained the same β-sheet structure
irrespective of the mode of addition, the longer Aβ(1–42) appeared to have an increase in β-sheet structure at the C-terminus when added to
phospholipid liposomes after vesicle formation. Since the Aβ(25–35) fragment is also neurotoxic, the full-length peptide may have more than one
pathway for toxicity.
© 2007 Elsevier B.V. All rights reserved.Keywords: Amyloid Aβ; Peptide–lipid interactions; Phospholipid membranes; Solid-state NMR; Structure; Metal interactions1. Introduction
The mechanisms that govern the progression of Alzheimer's
disease (AD), marked by the accumulation of neuronal plaques
consisting mainly of aggregated 39–42 residue amyloid-β
peptides (Aβ), have yet to be established. Aβ peptides are a
product of cleavage by the β- and γ-secretases of the larger
transmembrane amyloid precursor protein (APP) [1–3] and
aggregate to form amyloid fibrils (reviewed in [4]). While
structural models for Aβ(1–40) fibrils based on solid-state
NMR data have been presented [5], it is likely that soluble
oligomers of Aβ peptides are principally responsible for
cytotoxicity [4]. Both Aβ(1–40) and Aβ(1–42) have been
extensively studied for their cytotoxic effect, for which several⁎ Corresponding author.
E-mail address: fs@unimelb.edu.au (F. Separovic).
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doi:10.1016/j.bbamem.2007.05.004interrelated mechanisms are suggested: metal coordination by
histidines 6, 13 and 14 is implicated in oligomer formation [6],
and inducing Aβ insertion into phospholipids membrane
bilayers [6,7]. Copper and zinc ions (Cu2+ and Zn2+), found
at increased levels in neuronal plaques [8,9], can also undergo
Fenton-like chemistry and produce free radicals that may result
in both the observed dityrosine crosslinks between intermole-
cular Tyr10 residues [6,10,11], lipid peroxidation [12], and the
extensive oxidative stress observed in post mortem examination
of AD patient brain [13–15].
Significantly, the largely hydrophobic Aβ(25–35) fragment
of naturally occurring Aβ peptides does not have any known
direct metal binding or cross-linking potential, yet aggregates
much more readily than other fragments and is toxic toward
cultured cortical cells as well as neuronal cells [4,16] via
membrane interaction and bilayer disruption similar to the full-
length Aβ(1–42) [17–19]. Further investigation of this frag-
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cytotoxicity of the longer Aβ peptides.
We, therefore, examine the effect of Aβ(25–35) on mixed
phospholipid bilayers in the presence of metal ions and compare
structural changes of Aβ(25–35) to those of Aβ(1–42) in the
presence of phospholipids. Particular attention is directed
toward lipid membrane composition, which can influence the
formation of β-sheet structure [19]. Preferential interactions of
Aβ peptides with charged phospholipids as important regulators
of membrane disruption have been implicated in our previous
studies of Aβ(1–42) [20], together with other NMR results [21],
fluorescence and atomic force microscopy [22]. Consequently,
varying the lipid composition of membranes may aid in
understanding the progression of AD.
Cholesterol represents another important membrane compo-
nent, as sterols in general decrease membrane fluidity (or
conversely increase acyl chain order) [23]. The role of
cholesterol in modulating Aβ/lipid interactions, however,
remains controversial: cultured PC12 cells enriched with
cholesterol block β-amyloid toxicity and appear to reduce
lipid aggregation [24,25] while the cholesterol-lowering statin
drugs also slow the development of AD [26]. Other less
common lipids have also been found to promote peptide
aggregation, e.g. Aβ bound to GM1 ganglioside may seed fibril
development through ‘raft-like’ formation [27].
In addition to metals and lipid composition, the manner in
which the peptide is added to model membranes has bearing.
The distinction of peptide addition made in our previous studies
of Aβ(1–42) demonstrated that Aβ(1–42) disrupts model
membranes when incorporated within the lipid vesicles, while
peptide added after vesicle formation binds preferentially to the
phospholipid headgroups [19,20]. These modes of peptide
addition may sample different points in the kinetics of Aβ
interactions and AD progression. Associated peptide may
represent the toxic soluble Aβ oligomer interacting with a
membrane surface; alternatively, the “soluble” (non-amyloidic)
oligomer may actually preferentially partition into membranes
and be better represented by incorporated peptide, while the
associated peptide readily aggregates toward the insoluble,
amyloidic species.
The lipid charge, membrane order or ‘fluidity’ and peptide–
lipid interactions, together with metal ions, may play an
important role in inducing peptide toxicity and aggregation.
Therefore, we examined the effect of Aβ(25–35) on mixed
phospholipid bilayers together with metal ions and compared
structural changes of both Aβ(1–42) and Aβ(25–35) in the
presence of phospholipids.
2. Materials and methods
2.1. Materials
Synthetic deuterated 1-palmitoyl(d31)-2-oleoyl-sn-glycero-3-phospho-
choline (dPOPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-L-serine] (POPS), brain total lipid
extract and brain polar lipid extract (porcine) were purchased from Avanti Polar
Lipids (Alabaster, USA) and used without further purification. Cholesterol was
purchased from Sigma Aldrich (St. Louis, USA). Unlabelled Aβ(25–35)peptide, with sequence GSNKGAIIGLM was purchased through Auspep
(Melbourne, Australia). Specifically labelled Aβ(25–35) and Aβ(1–42)
peptides were made using standard FMOC-solid phase peptide synthesis [6],
purified by reverse phase HPLC and the products identified by mass
spectrometry with m/z of 1064.29 for Aβ(25–35) and m/z of 4519.11 for
Aβ(1–42). The peptides were 13C labelled with sequence: G SNK-[13C2]G
[13C1]A IIG[
13C1]LM for Aβ(25–35), and DAEFR HDSGY EVHHQ KLVFF
AEDVG SNK[13C2]G[
13C1]A IIG[
13C1]LM VGGVV IA for Aβ(1–42).
Note: residues of Aβ(25–35) are indexed herein to be consistent with that of
Aβ(1–42).
13C2-Gly,
13C1-Ala and
13C1-Leu were purchased from Cambridge Isotope
Laboratories (Andover, USA) and FMOC-succinamide (OSu) from Auspep
(Melbourne, Australia). FMOC-protected amino acids were synthesized and
purified for use in peptide synthesis.
2.2. FMOC-13C-labelled amino acid synthesis
Na2CO3 solution (1 M, 30 ml) was added to 1 g each of
13C1-Leu,
13C1-
Ala and 13C2-Gly at room temperature. A 12% mol excess of Fmoc-OSu in
MeCN (40 ml) was added to each reaction mixture drop-wise and the
reaction stirred, with white precipitate forming overnight. De-ionised water
(40 ml) was added to each solution and stirred until precipitate was
dissolved. The aqueous phases were extracted with diethyl ether (1×50 ml,
1×60 ml, 1×70 ml) and washed with de-ionised water (10 ml) with each
extraction. The aqueous phase was acidified to approximately pH 2.0 with
HCl (3 M) and extracted with dichloromethane (3×70 ml). Organic phases
were combined, dried over Na2SO4 and filtered. Solvent was removed under
vacuum, and the white crude product was recrystallised from dichloro-
methane/hexane, ethyl acetate/hexane and chloroform/hexane for leucine,
alanine and glycine, respectively. Crystallised product was dried under
vacuum [28]. The yields of FMOC-amino acids were 2.54 g (94%) and
0.17 g (6%) from first and second recrystallisations, respectively, for 13C1-
Leu; 3.24 g (93%) for 13C1-Ala; and 3.68 g (93%) and 0.27 g (7%) from
first and second recrystallisations, respectively, for 13C2-Gly.
2.3. NMR sample preparation
For solid-state NMR studies, multilamellar vesicles (MLV) were used rather
than LUV preparations. LUV typically have diameter of 100–200 nm and hence,
due to motional averaging, do not reveal the full axially symmetric 31P chemical
shift anisotropy (CSA) and 2H quadrupolar splittings (ΔνQ) of liquid lamellar-
phase lipid membranes. MLV were prepared by co-dissolving equal amounts of
dPOPC and POPS in chloroform and methanol (9:1) solution in a round bottom
flask, removing solvent under vacuum, re-dissolving the resulting lipid film in
3 mL 0.05 M Tris–HCl buffer (pH 7), and freeze–thawed several times using
liquid N2 and warm water. Typically 30 mg of lipid and 1.5 mL of solvent was
used to make several samples. For the sterol containing samples, dPOPC, POPS
and cholesterol (1:1:1 molar) were co-dissolved in solvent to prepare the MLVas
described above. Experiments were also conducted at pH 5 with no obvious
difference in the 31P lineshape and 2H quadrupolar splittings. Hence only spectra
at pH 7 are shown.
2.4. Incorporated Aβ
dPOPC/POPS (1:1) or dPOPC/POPS/cholesterol (1:1:1) were dissolved in
chloroform and methanol (9:1) solution in a round bottom flask and the solvent
removed under vacuum resulting in a lipid film. The filmwas suspended in 0.5ml
(0.05 M) Tris–HCl buffer (pH 7) and Aβ(25–35) or Aβ(1–42) dissolved in
hexafluoroisopropanol (HFIP) (Sigma Aldrich, St. Louis, USA) was added to the
suspension resulting in approximately 10% v/v HFIP. The mixture was freeze-
dried overnight and the film re-suspended with distilled water and freeze–thawed
for several cycles. The peptide to lipid molar ratio (P/L) was 1:30.
2.5. Associated Aβ
Aβ(25–35) or Aβ(1–42) was solubilized in HFIP and dried into a thin film.
MLV preparations were subsequently added at P/L of [1:30], followed by
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5 mg of lipid. Labelled peptide used for 13C NMR studies was also freeze-dried
from HFIP.
2.6. Addition of metal ions
Copper and zinc ions were prepared using 0.1 M copper glycinate (CuGly2)
solution or 0.1 M zinc glycinate solution (ZnGly2), respectively, by dissolving
1:2 mole ratio of metal chloride with glycine in de-ionised water. Copper and
zinc glycinate solution was added to the samples to give 1:1 mole ratio of metal
ions to peptide.
2.7. Solid-state NMR
NMR experiments were conducted on a Varian Inova 300MHz spectrometer
(Palo Alto, USA) operating at a resonance frequency of 300 MHz for 1H. Static
spectra were acquired at 28 °C, using a Doty (Colombia, USA) 5 mm double
resonance probe. 31P broad-line spectra were collected between 1.5 s recycle
delays with a proton-decoupled Hahn echo pulse sequence using a 4 μs π/2
pulse and 40 μs echo delay, acquired with a spectral width of 62.5 kHz, and
processed with 100 Hz exponential line broadening. Chemical shift was
referenced using 80% phosphoric acid (H3PO4) at 0 ppm.
2H broad-line spectra
were collected between 0.4 s recycle delays with a solid echo pulse sequence
[29] using a 6 μs π/2 pulse and effectual 40 μs echo delay, acquired with a
spectral width of 250 kHz, and processed as detailed below. 31P T2 and
13C
experiments 1D cross-polarisation (CP) experiments employed a 5 mm triple
resonance Doty (Columbia, USA) probe at 6 kHz magic angle spinning (MAS).
31P T2 measurements were made using a Hahn-echo sequence with a 5 μs π/2
pulse and variable echo delays set at multiples of the rotor rotation period; non-
linear data were fit to a single exponential decay in all cases using gnuplot 4.0
[30]. 13C CP-MAS spectra [31] were typically signal averaged over 30-k scans
with 2 s recycle delays, using 55.5 kHz proton and 61.5 kHz 13C field strengths
for 1 ms cross-polarisation contact time, acquired with a spectral width of
30 kHz, and processed with 50 Hz exponential line broadening. 13C chemical
shifts were referenced externally to tetramethylsilane (TMS) at 0 ppm.
2.8. 2H spectra dePaking, and order parameters of lipid acyl chains
2H spectra were collected with shortened pre-acquisition delays to permit
post hoc selection of the echo maximum. Data to be used for subsequent
dePaking were processed in NMRpipe [32] to DC-correct, left-shift to the echo-
maximum, and apodize with a Gaussian function (300 Hz decay constant)Fig. 1. 2H and 31P NMR spectra of: (a, b) dPOPC/POPS bilayers withbeginning at 1.2 ms (and un-attenuated at earlier time), zero-fill to 2048 points,
Fourier-transform and only zero-order phase corrected to generate static,
unoriented power spectra. Oriented spectra were generated by numerically
“dePaking” using Single Value Decomposition (SVD) [33] as well as a
straightforward nonlinear least squares approach. The computer code was
written in C and used functions freely available from the GNU Scientific Library
(GSL) v1.7 [34] to handle the SVD and least squares fitting mechanics. Order
parameters were calculated simply by measuring the quadrupolar splitting in the
calculated 0°-oriented spectrum for each palmitoyl-CDn acyl chain position and
divided by 255 kHz, the static coupling constant [35,36].3. Results
3.1. Effect of Aβ(25–35) and metals on
cholesterol–phospholipid bilayers
The association of Aβ(25–35) with the phospholipid bilayer
resulted in a small but significant reduction in the 2H
quadrupolar splitting but little effect on the 31P CSA. These
results indicated that the addition of Aβ(25–35) to the lipid
bilayer resulted in more ‘disorder’ in the deuterated acyl region
of the membrane and less effect on the phosphate headgroups
(Fig. 1a–d, Table 1). Subsequent addition of Cu2+ after
association of Aβ(25–35) with the bilayer resulted in a slight
increase in the 2H quadrupolar splitting and a decrease in 31P
CSA together with T2 broadening (due to the presence of the
paramagnetic copper) of the lineshape. Although the effect of
changes in T2 on the lineshape are complicated since T2 is
anisotropic across the 31P powder pattern [37,38], the changes
indicate disordering in the lipid headgroup region and
restriction in phospholipid acyl chain motions (Fig. 1e, f).
Similar results were observed with the addition of Zn2+ ions
(Fig. 1g, h).
The presence of cholesterol in membrane bilayers is known
to promote lipid domain or ‘raft’ formation and an increase in
lipid order (or decrease in lipid ‘fluidity’) with increasing
cholesterol level. If membrane disruption or destabilization is(c, d) associated Aβ(25–35), plus (e, f) copper, or (g, h) zinc ions.
Table 1
2H (CD2, CD3) quadrupolar splitting (ΔνQ) and
31P chemical shift anisotropy
(Δσ) for dPOPC/POPS bilayers with 1:30 peptide/lipid ratio at 28 °C in Tris–
HCl pH=7.2. CD2 and CD3 quadrupolar splittings (ΔνQ) are taken from the 90°
edges of the powder pattern
Observed nuclei 2H 31P
(ΔνQ) kHz (Δσ) ppm T2 (ms)
Sample CD2±0.3 CD3±0.1 CSA±2 ±0.3
a dPOPC/POPS (1:1) 25 2.5 −43 6.2
b dPOPC/POPS (1:1)+
Aβ(25−35) incorp.
27 2.3 −45 7.0
c dPOPC/POPS (1:1)+
Aβ(25−35) assoc.
24 2.3 −47 1.2
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cholesterol may play a role in influencing membrane integrity.
31P and 2H NMR spectra showed that cholesterol resulted in a
significantly greater 2H quadrupolar splitting and narrower 31P
CSA (Table 2a) compared to pure dPOPC/POPS bilayers (Table
1a) [20]. This result is consistent with the understanding in the
literature of the effects of cholesterol on lipid bilayers, and in
particular on the 31P powder patterns, arising from the
separation of lipid headgroups by intercalation of cholesterol
between the lipids [36].
When Aβ(25–35) was associated, an increase in 2H splitting
but not in the 31P CSA was observed (Table 2). Following
subsequent addition of Cu2+ ions, a significant decrease in 31P
CSA (together with T2 broadening due to the strong
paramagnetic effect of the copper) was observed, with only
a slight increase in the quadrupolar splittings (Table 2); while
Zn2+ addition also had a slight increase in quadrupolar splitting
but no significant effect on the phosphorus headgroup. Addition
of either Cu2+ or Zn2+ ions to the cholesterol–phospholipid
bilayer in the absence of the peptide resulted in a slight increase
in the quadrupolar splitting and very little effect on the 31P CSA
(Table 2). A decrease in signal to noise ratio was also observed
for the phosphorus headgroup in the presence of Cu2+ ions in
comparison to the 2H spectra due to the paramagnetic relaxation
properties of copper, indicative of a preferential interaction of
Cu2+ for the lipid headgroup.Table 2
Effect of Aβ(25–35) and cholesterol on 2H (CD2, CD3) quadrupolar splitting
(ΔνQ) and
31P chemical shift anisotropy (Δσ) of dPOPC/POPS bilayers
Observed nuclei 2H 31P
(ΔνQ) kHz (Δσ) ppm
dPOPC/POPS/cholesterol (1:1:1) CD2
(±0.3)
CD3
(±0.1)
CSA
(±2)
a Lipid+Cholesterol 46 4.2 −40
b Lipid+Cholesterol+Aβ(25–35) 48 4.6 −41
c Lipid+Cholesterol+Aβ(25–35)+Cu2+ 49 4.9 −33
d Lipid+Cholesterol+Aβ(25–35)+Zn2+ 49 4.4 −40
e Lipid+Cholesterol+Cu2+ 49 5.0 −41
f Lipid+Cholesterol+Zn2+ 49 4.8 −43
CD2 and CD3 quadrupolar splittings (ΔνQ) are taken from the 90° edges of the
powder pattern.3.2. NMR studies of Aβ(25–35) with brain lipids
Since studies have shown a preference for Aβ(1−42) to
interact with charged phospholipids [39,40], total extract and
the polar extract of brain lipids were used to probe the effect of
lipid composition with respect to peptide interaction and
membrane stability. The experiments carried out using natural
brain extracts were limited to 31P NMR experiments and did not
include 2H NMR experiments due to the absence of deuterium
labels in the lipid acyl chains. The results indicated that no
significant changes were seen in the 31P line shape upon
addition of Aβ(25–35) to either total brain lipid extract and the
polar lipid extract. While subsequent addition of Zn2+ also had
no effect, Cu2+ ions added after the association of Aβ(25–35)
caused a decrease in bulk 31P CSA together with the appearance
of an isotropic peak in the polar brain lipid extract (as seen in
our earlier spectra [20]). Since the presence of Cu2+ did not
induce membrane disruption for the total brain lipid extract but
did for the polar extract, it is evident that lipid composition is
critical in maintaining membrane integrity in the presence of
Aβ(25–35) and Cu2+ ions.
3.3. CP-MAS NMR of membrane-associated 13C specifically
labelled Aβ(25–35)
Structure-related information was obtained for Aβ(25–35)
in a phospholipid bilayer using peptide specifically labelled in
the middle of the sequence and near the C-terminus. 13C
spectra of labelled Aβ(25–35) peptide as a dry powder prior to
incorporation or association of the peptide into model lipid
membranes are shown in Fig. 2a. Peptide structural changes as
suggested by changes in carbon chemical shift were compared
with reference to polypeptide conformational studies of 13C
carbonyl and C(α) chemical shifts using solid-state NMR
[41,42]. The chemical shift of specific labelled sites of the
incorporated peptide (Fig. 2b) when compared to the labelled
Aβ(25–35) peptide powder indicated an upfield shift for theFig. 2. 13C-CPMAS NMR spectra of Aβ(25–35): (a) dry peptide powder, (b)
incorporated in PC/PS lipid bilayers, and (c) associated with PC/PS lipid
bilayers.
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(from 174 to 173 ppm) and no significant change for Gly29
(43 ppm) from the initial random coil shift [41,42] of the dry
peptide. Associated peptide (Fig. 2c) had a similar effect when
added to the PC/PS membrane with a slightly more upfield
shift for the carbonyls (171 ppm) when compared to the
incorporated peptide. Although carbon chemical shifts were
similar for both the associated and incorporated peptides, T2
measurements of the 31P headgroups indicated that the
phospholipid headgroup interactions for the associated species
was stronger, as observed by the reduction in T2 relaxation time
from ∼6.2 ms (lipid alone) to ∼1.8 ms, whereas incorporated
Aβ(25–35) gave a T2 of ∼7 ms similar to that of pure lipids.
As a result of the anisotropic nature of T2 [37,38], MAS
techniques were used to measure T2 in order to determine the
gross effect of the peptide on the phospholipids rather than a
detailed study, which would require measurement of that
anisotropy to explain the lineshape change. Interestingly, only
one peak was seen by 31P, suggesting that the two
phospholipids were in a similar environment, although the
linewidth as a result of the short NMR T2 would preclude
resolving the resonances. Incorporated Aβ(25–35) also caused
a significant increase in the 2H quadrupolar splittings and the
31P CSA, indicating perturbation of both the acyl region as well
as the phosphorus headgroup of the bilayer. The 2H acyl chain
order parameter from dePaked spectra showed an increase in
order at the CD2 positions nearer to the lipid headgroups with
less effect in the CD2 position toward the end of the chain and
the terminal CD3 when the peptide was incorporated in lipid
vesicles compared to the associated species (Fig. 3).
3.4. CP-MAS NMR of 13C specifically labelled Aβ(1–42)
Structure-related information was obtained for Aβ(1–42) in
phospholipid bilayers. 13C chemical shifts of labelled Aβ(1–
42) were obtained as: (i) a dry powder, (ii) when incorporated in
lipid bilayers, and (iii) when associated with lipid bilayers. The
Aβ(1–42) peptide was labelled at the C-terminal end region, at
the same residues as for the Aβ(25–35) fragment used in theFig. 3. 2H order parameter plot of dePaked spectra from deuterated acyl chains of
dPOPC/POPS: (i) –○– lipid order profile alone; (ii) –▪– lipid order profile with
incorporated Aβ(25–35); and (iii) –•– lipid order profile with associated
Aβ(25–35). The order parameters are customarily assumed to correspond to the
carbon position, with the widest splitting being assigned to C-2 and the
narrowest to the terminal methyl.studies. Chemical shift comparison of both the incorporated and
the associated peptide relative to the peptide as a dry powder
(HFIP pre-treated as discussed in Materials and methods)
indicated an upfield shift, consistent with a change from α-
helical to β-sheet for the carbonyl resonances (Fig. 4, Table 3)
[41,42].
From our experiments, the dry Aβ(1–42) peptide displayed
β-sheet propensity at Gly29 and helical propensity at both
Ala30 and Leu34. We were unable to resolve Gly29 C(α)
chemical shift due to overlapping acyl-lipid peaks when the
peptide was in the presence of phospholipids. However, the
13CO resonances shifted from 178 ppm, indicative of α-
helical structure [41,42], to 173 ppm (for incorporated) and
171 ppm (for associated), indicative of β-sheet structure
[41,42], for the Aβ(1–42) peptide with POPC/POPS bilayers
(Fig. 4, Table 3). The changes in 13C chemical shift as seen by
CP-MAS experiments upon association of Aβ(1–42) with the
lipid bilayer suggest the peptide adopted a β-sheet conforma-
tion [41,42] toward the C-terminus where the labelled residues
(29, 30 and 34) are located. This result is complementary to
circular dichroism (CD) data published in earlier studies [20],
where an increase in β-sheet conformation was also observed
when Aβ(1–42) was associated with membrane vesicles. The
carbonyl resonances of associated peptide have a higher
upfield shift than the incorporated peptide, which may suggest
Aβ(1–42) adopts a more β-sheet-like structure when
associated.
4. Discussion
The importance of metal–peptide interactions mediated
through binding to histidine residues and promoting structural
changes for both full-length Aβ(1–40) and Aβ(1–42) has been
correlated to the neurotoxic properties of Aβ peptides.
However, the shorter Aβ(25–35) peptide fragment also exhibits
neurotoxicity, but does not contain the metal coordinating
histidine residues. This suggests Aβ can exhibit neurotoxicity
through a variety of alternative pathways [16]. Lipid composi-
tion of the membrane has been shown to be important for
seeding peptide aggregation, with Aβ appearing to bind
preferentially to negatively charged over neutral lipids. Lipid
charge distribution has been shown to be involved in signalling
cell death, for example, phosphatidylserine (PS) lipid transloca-
tion from the inner to the outer membrane leaflet has been
shown to occur as an apoptotic trigger in cells [43]. Also,
aggregation of the peptide is affected when membrane fluidity
or order is altered, for example, in the presence of cholesterol.
We have examined the effect of associated or incorporated
Aβ(25–35) in lipid membranes of different fluidity and changes
in peptide structure when added to lipid membranes using solid-
state NMR. For comparison to our earlier studies of Aβ(1–42)
in phospholipid bilayers [20], we used a L/P ratio of 30:1.
Aβ(25–35) structural change was subsequently compared to
full-length Aβ(1–42) in phospholipid membranes. Associated
peptide could represent ‘soluble’ Aβ interacting with a
membrane surface, whereas incorporated peptide could repre-
sent Aβ already within a membrane bilayer.
Fig. 4. 13C-CPMAS NMR spectra of labelled Aβ(1−42) associated with dPOPC/POPS bilayer. The Aβ(1–42) sequence is given with *(Cα) and #(CO) indicating
residue label position.
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metals on membrane bilayer
Our observations of the effect of Zn2+ and Cu2+ ions on the
membrane integrity showed the formation of smaller lipid
structures indicative of membrane disruption by the ions [9].
Metal coordination of these ions to the histidine residues of the
full-length Aβ(1–42) peptide has been shown to be important
for Aβ toxicity where a decrease in peptide toxicity was seen
using methylated histidine mutant peptides that bind metals with
an altered coordination mode compared to wild-type peptide [6].
The Aβ(25–35) fragment contains no histidine residues, thus
excluding obvious potential for direct metal binding, although
the effect of Aβ(25–35) andmetal ions on bilayer integrity could
still be studied. Our data suggest that Aβ(25–35) inserts less
deeply into the bilayer when associated with phosphatidylcho-
line/phosphatidylserine (PC/PS) membranes as a dry peptide
film than when incorporating peptide during vesicle formation.
The association with peptide results in a decrease in 2H NMR
quadrupolar splitting, increase in 31P CSA and a significant
decrease in 31P T2 relaxation time from 6.2 to 1.8 ms, which
indicates decreases in lipid acyl chain order and direct
perturbations of phospholipids headgroup consistent with
peptide located more at the interface between the membrane
and aqueous solution. Previous neutron diffraction studies ofTable 3
Comparison of 13C-CPMAS chemical shifts of Aβ(1–42) specifically enriched
at 13Cα of Gly29 and 13CO of Ala30 and Leu34 as a dry peptide powder and
with dPOPC/POPS lipid bilayers at 1:30 peptide/lipid ratio in Tris–HCl pH=7.2
at 28 °C.
13Cα (ppm) 13CO (ppm)
Aβ(1–42) (dry powder) 44 178
Incorporated Aβ(1–42) in lipid 43 (broad peak) 173
Associated Aβ(1–42) in lipid 43 (broad peak) 171similarly associated Aβ(25–35) [44–46] also indicate at least a
partial preference for the more hydrophobic membrane environ-
ment over the aqueous membrane interface, and positions the
penultimate Leu34 residue∼15 Å from the centre of the∼30 Å
hydrophobic distance between glycerol backbones [47]. These
results together with our present study indicate the Aβ(25–35) is
partially inserted into the bilayer, while still interacting with the
31P headgroups. Addition of Cu2+ ions subsequent to peptide
addition only affected the 31P headgroups and reduced the 31P
CSA with an increase in T2 broadening, consistent with
paramagnetic relaxation. Addition of Zn2+ after Aβ(25–35)
peptide did not lead to significant changes.
In contrast, incorporated Aβ(25–35) increased 2H NMR
quadrupolar splittings indicating an increase in lipid acyl chain
order akin to the effect of cholesterol [23], and had less effect
than associate peptide on 31P CSA and no significant impact on
31P T2 relaxation time. These results indicate that Aβ(25–35)
was more deeply inserted in the membrane.
4.2. Effect of cholesterol on Aβ(25–35) insertion into
membrane bilayer
The presence of cholesterol in a membrane bilayer orders the
lipid acyl region while ‘disordering’ the headgroup due to
incorporation of the sterol into the membrane. Cholesterol
increased the lipid 2H quadrupolar splitting of the chains and
decreased the 31P CSA of the headgroup as seen by Davis et al.
[36]. The effect of Aβ(25–35) on the lipid bilayer (Table 1c) was
reduced by the presence of cholesterol (Table 2b), which
suggested that cholesterol could prevent bilayer insertion of
Aβ(25–35). Since cholesterol decreases membrane fluidity, the
increase in lipid acyl-chain order may reduce peptide insertion.
Cholesterol also tends to preserve membrane integrity and,
unsurprisingly, the effect of Aβ(25–35) on both the total brain
lipid extract (with cholesterol) and the polar brain lipid extract
2406 T.-L. Lau et al. / Biochimica et Biophysica Acta 1768 (2007) 2400–2408(without cholesterol) was different. For the total brain lipid
extract there was no significant perturbation of the 31P lipid
headgroup while for the polar brain extract, there was a
significant increase in 31P isotropic phase with the addition of
Cu2+ ions. The appearance of this isotropic phase, representative
of smaller lipid structures as seen in earlier studies [20] indicated
that the membrane integrity was destabilized for the more polar
lipid in the presence of Aβ(25–35) and Cu2+ ions. These data
suggest that, in the presence of Aβ, cholesterol may have a
stabilizing role on membrane structure.
4.3. Structural characteristics of membrane-associated and
-incorporated Aβ
CP-MAS data using specifically 13C labelled peptide provides
information on the peptide structure in association with lipid
vesicles. The data indicated that both Ala30 and Leu34 carbonyl
carbons had more β-sheet structure than the peptide powder,
more so for associated than incorporated Aβ(25–35) in PC/PS
bilayers, but with little such differential effect at the α-carbon of
Gly29 in both cases. The interaction of the native Alzheimer's
peptide C-terminal fragment Aβ(29–42) with neutral phospho-
lipid bilayers by solid-state NMR has been reported [48]. The
results for this longer peptide also support a β-sheet oligomeric
association of the peptide at the bilayer interface. Interestingly,
although we expected the hydrophobic transmembrane region of
Aβ(1–42) to exhibit greater preference for helical structure upon
membrane interaction, the CD studies reported earlier [20]
together with our 13C CP-MAS results from specific labels in the
hydrophobic region of Aβ(1–42) showed a change from α-
helical as a dry powder to β-sheet structure when both associated
and incorporated with phospholipid vesicles. Although not in
association with lipid, in amyloidic fibril form, and significantly
two residues shorter, the structural model from Tycko and
coworkers based on solid-state NMR data [5] also showβ-strand
conformations for residues 12–24 and 30–40 of Aβ(1–40).
4.4. Comparison of Aβ(25–35) with Aβ(1–42)
We have shown previously that Aβ(1–42) behaves similarly
to our present observation on Aβ(25–35) when associated with
phospholipid bilayers, as it binds to the phosphorus headgroup
causing a decrease in spin–spin (T2) relaxation time; phospho-
lipid headgroup binding of Aβ(1–42) was further confirmed by
31P magic angle spinning SS-NMR with the appearance of a
lipid–Aβ bound phase together with a peptide-free lipid phase in
large unilamellar vesicles [49]. This commonality suggests that
the Aβ(25–35) region within the full-length peptide may be
involved in phospholipid interaction. Incorporation of Aβ(1–42)
and Aβ(25–35) in phospholipid membranes, however, yielded
diverse results. Aβ(1–42) when incorporated destabilizes the
bilayer, as reported previously [20], while Aβ(25–35) inserted
into the hydrophobic acyl-chain region of the phospholipid
membrane and enhanced membrane stability, as indicated by the
absence of an isotropic peak in the 31P NMR spectra.
Although more membrane associated Aβ peptide structural
detail is necessary before probable toxicity mechanisms can bedeveloped, the weaker but similar shift toward β-sheet structure
of Aβ(25–35) asAβ(1–42), together with evidence of headgroup
interactions,may reflect partial insertion of the shorter peptide and
aggregation of the full-length peptide largely on the membrane
surface, respectively [21], suggesting that the toxic form of Aβ
may reside on the bilayer surface with β-sheet structural
propensity driven somewhat by the Aβ(25–35) fragment.
5. Conclusion
Aβ(25–35) appeared to promote Cu2+ destabilization of the
membrane of polar lipid brain extracts. Althoughmetal ions could
adhere non-specifically to amyloid oligomers, our earlier NMR
results [20] also showed that Cu2+ alone but not Zn2+ destabilized
PC/PS bilayers without peptide. Aβ(25–35), if inserted through
to the hydrocarbon–water interface of the bilayer, could allow
more accessibility for Cu2+ binding for the polar lipid extract than
for the less fluid or more ordered membrane system, such as total
brain lipid extract with cholesterol. Structural comparison of
Aβ(1–42) and Aβ(25–35) at similar residues suggested that
Aβ(1–42) undergoes an increase in β-sheet structure in the C-
terminal region while Aβ(25–35) maintained its conformation in
the presence of phospholipids. Since both peptides are cytotoxic
to cell cultures, the conformational change towards β-sheet may
be a crucial change required for Aβ(1−42) to exhibit cytotoxicity.
Interestingly, Aβ(25–35) has been shown to mediate the effects
of the full-length peptide and to be homologous to the tachykinin
neuropeptide family [50]. Our previous studies showed altera-
tions to the metal coordination by Aβ histidine residues
attenuated peptide toxicity [6]. It seems Aβ(25–35), which
lacks the histidine residues required for metal coordination,
adopts a different toxic pathway that does not involve metal
coordination [51]. This pathway can also be engaged by Aβ(1–
42) as an alternative tometal dependent toxicity since Aβ(25–35)
is embedded in the Aβ(1–42) sequence. However, the methio-
nine is C-terminal in Aβ(25–35), which may play a crucial role
[51,52] and, intriguingly, Aβ(25–36) with one additional residue
is not toxic to cultured neurons [51]. If the cytotoxic pathway of
Aβ(25–35) represents an alternate toxic pathway for the full-
length peptide, and the composition of the membrane plays a role
in the advancement of dementia, then the disease could be
amplified by a deficiency in maintaining ‘normal’ lipid composi-
tion crucial for preserving membrane order or fluidity.
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